Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

United Therapeutics Q4 GAAP EPS $4.36 Beats $4.19 Estimate, Sales $614.70M Beat $575.87M Estimate

Author: Benzinga Newsdesk | February 21, 2024 07:01am
United Therapeutics (NASDAQ:UTHR) reported quarterly earnings of $4.36 per share which beat the analyst consensus estimate of $4.19 by 4.06 percent. This is a 63.3 percent increase over earnings of $2.67 per share from the same period last year. The company reported quarterly sales of $614.70 million which beat the analyst consensus estimate of $575.87 million by 6.74 percent. This is a 25.07 percent increase over sales of $491.50 million the same period last year.

Posted In: UTHR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist